NCT03075358 is a Phase 3 clinical trial of Lidocaine spray in Uterine Bleeding, sponsored by Chiang Mai University.

Who is sponsoring NCT03075358?

NCT03075358 is sponsored by Chiang Mai University.

What drugs are being tested in NCT03075358?

Interventions in NCT03075358: Lidocaine spray, Normal saline spray.

What condition does NCT03075358 study?

NCT03075358 studies Uterine Bleeding.

Is NCT03075358 still recruiting?

NCT03075358 is currently completed. Last updated 27 March 2018.

Last reviewed 2018-03-27 · How we verify

NCT03075358

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial

Completed Phase 3 Last updated 27 March 2018

What this trial tests

Phase 3 trial testing Lidocaine spray in Uterine Bleeding in 240 participants. Completed in 15 January 2018.

Timeline

6 March 2017

Primary endpoint
15 January 2018

15 January 2018

Quick facts

Lead sponsor	Chiang Mai University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	240
Start date	6 March 2017
Primary completion	15 January 2018
Estimated completion	15 January 2018
Sites	1 location across Thailand

Drugs / interventions tested

Lidocaine spray — full drug profile →
Normal saline spray

Conditions studied

Uterine Bleeding — all drugs for Uterine Bleeding →

Sponsor

Chiang Mai University

Who can join

20 and older, female only, with Uterine Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Endometrial aspiration biopsy has been accepted as a diagnostic procedure of choice for women with abnormal uterine bleeding to examine endometrial pathology. The procedure has high accuracy comparing to conventional fractional curettage. However, it is associated with significant pain during the procedure. In general, there is no specific recommendation regarding the proper anesthesia used during the procedure. The aim of this study is to examine the effect of lidocaine spray for reducing pain during the endometrial aspiration procedure by comparing it with placebo and no intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lidocaine spray

Trials testing the same drug.

NCT07299630 — Blocking Sphenopalatine Ganglion by Intranasal Lidocaine Spray in Partial Turbinectomy Surgeries · Phase 3 · recruiting
NCT06918340 — Evaluation of Analgesic Efficacy of Lidocaine and Diclofenac Spray in Radial Artery Blood Gas Sampling by Visual Analogu · Phase 4 · active not recruiting
NCT06661967 — Topical Oral Anesthesia Adjuncts in Conventional Intubation on First-Pass Success Rate · NA · recruiting
NCT06585748 — Lidocaine Spray Use on Patients Comfort in Undergoing Bladder Catheterization · recruiting

Other recruiting trials for Uterine Bleeding

Currently open trials in the same condition.

NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06953076 — Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study · recruiting
NCT06308172 — Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial · NA · recruiting

Other Chiang Mai University trials

Trials by the same sponsor.

NCT07366775 — A Telenursing Program to Support Diabetes Self-Management · NA · active not recruiting
NCT07032610 — Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents · not yet recruiting
NCT06978621 — Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV · Phase 3 · recruiting
NCT06905041 — Preoperative Anemia Affected to Postoperative Outcomes in Liver Resection · not yet recruiting
NCT07476404 — Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03075358 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chiang Mai University
Last refreshed: 27 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03075358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing